You are here:Home
»
Growth Factors, Cytokines
»
Growth Factors-EMAP II
»
Endothelial Monocyte Activating Polypeptide II (EMAP II), Recombinant, Human
Endothelial Monocyte Activating Polypeptide II (EMAP II), Recombinant, Human
Pricing
For pricing information, USA customers sign in. Outside USA? Please contact your distributor for pricing. Specifications
| Endothelial-Monocyte Activating Polypeptide II (EMAP II) is a novel cytokine that is an antiangiogenic factor in tumor vascular development, and strongly inhibits tumor growth. Recombinant human EMAP II is an 18.3kDa protein containing 166 amino acid residues. | | | Catalog # | E3015 | | Source | E.coli | | Form | Sterile filtered solution, lyophilized without additives. | | Stability | The lyophilized protein is stable for a few weeks at room temperature, but best stored at -20°C. Reconstituted EMAP II should be stored in working aliquots at-20°C. | | Purity | 98% by SDS-PAGE and HPLC. | | Endotoxin | 0.1ng/ug (1EU/ug). | | Reconstitution | We recommend a quick spin followed by reconsitution in water to | | a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers and stored at 4°C for 1 week or -20°C for future use. | | Biological Activity | Determined by the apoptotic effect on MCF-7 cells (human breast carcinoma cells) using a concentration of 20-40ng/ml. | | Country of Origin | USA | | Important Note | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
External Links
|